REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 166 filers reported holding REVANCE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $386 | -54.4% | 33,683 | +0.7% | 0.00% | 0.0% |
Q2 2023 | $847 | -38.1% | 33,454 | -21.3% | 0.00% | -50.0% |
Q1 2023 | $1,369 | +41.0% | 42,490 | -19.2% | 0.00% | +100.0% |
Q4 2022 | $971 | -99.9% | 52,608 | +4.0% | 0.00% | -50.0% |
Q3 2022 | $1,366,000 | +95.7% | 50,598 | +0.2% | 0.00% | +100.0% |
Q2 2022 | $698,000 | -29.3% | 50,487 | -0.3% | 0.00% | 0.0% |
Q1 2022 | $987,000 | +19.5% | 50,622 | +0.0% | 0.00% | 0.0% |
Q4 2021 | $826,000 | -41.5% | 50,599 | -0.3% | 0.00% | -50.0% |
Q3 2021 | $1,413,000 | -21.6% | 50,734 | -16.6% | 0.00% | 0.0% |
Q2 2021 | $1,803,000 | +13.0% | 60,818 | +6.5% | 0.00% | 0.0% |
Q1 2021 | $1,596,000 | -1.4% | 57,100 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $1,618,000 | +23.5% | 57,100 | +9.6% | 0.00% | 0.0% |
Q3 2020 | $1,310,000 | +3.0% | 52,100 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $1,272,000 | +95.7% | 52,100 | +18.7% | 0.00% | +100.0% |
Q1 2020 | $650,000 | +1.4% | 43,900 | +11.1% | 0.00% | 0.0% |
Q4 2019 | $641,000 | +4.7% | 39,500 | -16.1% | 0.00% | 0.0% |
Q3 2019 | $612,000 | +0.2% | 47,100 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $611,000 | +23.2% | 47,100 | +49.5% | 0.00% | 0.0% |
Q1 2019 | $496,000 | -21.8% | 31,500 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $634,000 | -30.1% | 31,500 | -13.7% | 0.00% | 0.0% |
Q3 2018 | $907,000 | -9.5% | 36,500 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $1,002,000 | +11.5% | 36,500 | +25.0% | 0.00% | 0.0% |
Q1 2018 | $899,000 | -12.3% | 29,200 | +1.9% | 0.00% | 0.0% |
Q4 2017 | $1,025,000 | +59.7% | 28,662 | +23.0% | 0.00% | 0.0% |
Q3 2017 | $642,000 | +4.4% | 23,300 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $615,000 | +26.8% | 23,300 | -0.0% | 0.00% | 0.0% |
Q1 2017 | $485,000 | +24.0% | 23,301 | +23.3% | 0.00% | 0.0% |
Q4 2016 | $391,000 | +27.8% | 18,900 | 0.0% | 0.00% | – |
Q3 2016 | $306,000 | +19.1% | 18,900 | 0.0% | 0.00% | – |
Q2 2016 | $257,000 | -22.1% | 18,900 | 0.0% | 0.00% | -100.0% |
Q1 2016 | $330,000 | -41.8% | 18,900 | +13.9% | 0.00% | 0.0% |
Q4 2015 | $567,000 | +28.9% | 16,600 | +12.2% | 0.00% | 0.0% |
Q3 2015 | $440,000 | +0.2% | 14,800 | +7.7% | 0.00% | 0.0% |
Q2 2015 | $439,000 | – | 13,738 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 1,558,426 | $42,779,000 | 61.17% |
Essex Woodlands Management, Inc. | 3,342,047 | $91,739,000 | 21.30% |
Sio Capital Management, LLC | 101,292 | $2,780,000 | 1.54% |
Fosun International Ltd | 472,532 | $12,971,000 | 0.66% |
Rhenman & Partners Asset Management AB | 203,181 | $5,577,000 | 0.57% |
ArrowMark Colorado Holdings LLC | 1,804,275 | $49,527,000 | 0.46% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 87,355 | $2,398,000 | 0.30% |
FOX RUN MANAGEMENT, L.L.C. | 18,477 | $507,000 | 0.16% |
Phoenix Investment Adviser LLC | 2,400 | $66,000 | 0.12% |
Quinn Opportunity Partners LLC | 33,100 | $909,000 | 0.12% |